Trade BioCryst - BCRX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.49 |
| Open | 7.64 |
| 1-Year Change | 0.26% |
| Day's Range | 7.52 - 7.83 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | 7.83 | 0.16 | 2.09% | 7.67 | 7.85 | 7.50 |
| Jul 25, 2024 | 7.52 | 0.13 | 1.76% | 7.39 | 7.72 | 7.35 |
| Jul 24, 2024 | 7.37 | 0.03 | 0.41% | 7.34 | 7.54 | 7.31 |
| Jul 23, 2024 | 7.43 | 0.08 | 1.09% | 7.35 | 7.58 | 7.26 |
| Jul 22, 2024 | 7.39 | 0.20 | 2.78% | 7.19 | 7.42 | 7.11 |
| Jul 19, 2024 | 7.12 | 0.08 | 1.14% | 7.04 | 7.26 | 6.99 |
| Jul 18, 2024 | 7.03 | -0.16 | -2.23% | 7.19 | 7.29 | 7.02 |
| Jul 17, 2024 | 7.25 | -0.16 | -2.16% | 7.41 | 7.63 | 7.23 |
| Jul 16, 2024 | 7.60 | 0.38 | 5.26% | 7.22 | 7.61 | 7.22 |
| Jul 15, 2024 | 7.15 | -0.06 | -0.83% | 7.21 | 7.41 | 7.13 |
| Jul 12, 2024 | 7.13 | 0.02 | 0.28% | 7.11 | 7.20 | 6.98 |
| Jul 11, 2024 | 7.01 | 0.33 | 4.94% | 6.68 | 7.14 | 6.65 |
| Jul 10, 2024 | 6.47 | 0.00 | 0.00% | 6.47 | 6.49 | 6.34 |
| Jul 9, 2024 | 6.47 | 0.08 | 1.25% | 6.39 | 6.54 | 6.37 |
| Jul 8, 2024 | 6.40 | -0.16 | -2.44% | 6.56 | 6.62 | 6.36 |
| Jul 5, 2024 | 6.49 | 0.13 | 2.04% | 6.36 | 6.52 | 6.34 |
| Jul 3, 2024 | 6.39 | -0.18 | -2.74% | 6.57 | 6.73 | 6.39 |
| Jul 2, 2024 | 6.52 | -0.14 | -2.10% | 6.66 | 6.79 | 6.52 |
| Jul 1, 2024 | 6.64 | 0.50 | 8.14% | 6.14 | 6.70 | 6.14 |
| Jun 28, 2024 | 6.17 | 0.05 | 0.82% | 6.12 | 6.19 | 6.00 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BioCryst Company profile
BioCryst (BCRX) is a commercial-stage biotech firm that discovers novel, oral, small-molecule medicines.
The company focuses on oral treatments for rare diseases in which significant unmet medical needs exist. BioCryst’s drug portfolio consists of ORLADEYO for prevention of hereditary angioedema. ORLADEYO has been approved in the US, EU, UK, Japan and UAE. Other drugs like RAPIACTA, RAPIVAB and PERAMIFLU are approved in select geographies.
The company is developing an oral small molecule Factor D inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases.
According to the company, its focus on rare diseases market helps it control costs effectively. BioCryst selects disease targets and product candidates in which a small molecule would offer a significant benefit over existing products or would be the first to market.
BioCryst’s US headquarters is located in Durham, North Carolina while its European headquarters is in Dublin, Ireland. Jon P Stonehouse is the chief executive officer and William P Sheridan is the chief medical officer of BioCryst.
The company was founded in 1966. It completed its initial public offering (IPO) in March 1994 and is listed on the Nasdaq stock exchange under the ticker symbol BCRX. According to the company’s price history, BCRX stock price hit an all-time high of $37.25 on 1 March 2000.
You can follow the ups and downs of the BioCryst stock price at Capital.com. Always stay on top of the latest price developments with our live BCRX stock chart.
| Industry: | Bio Therapeutic Drugs |
4505 Emperor Blvd Ste 200
DURHAM
NORTH CAROLINA 27703-8457
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com